Literature DB >> 9851369

Microscopic observations of the different morphological changes caused by anti-bacterial peptides on Klebsiella pneumoniae and HL-60 leukemia cells.

S C Chan1, W L Yau, W Wang, D K Smith, F S Sheu, H M Chen.   

Abstract

Natural anti-bacterial peptides cecropin B (CB) and its analogs cecropin B-1 (CB-1), cecropin B-2 (CB-2) and cecropin B-3 (CB-3) were prepared. The different characteristics of these peptides, with amphipathic/hydrophobic alpha-helices for CB, amphipathic/amphipathic alpha-helices for CB-1/CB-2, and hydrophobic/hydrophobic alpha-helices for CB-3, were used to study the morphological changes in the bacterial cell, Klebsiella pneumoniae and the leukemia cancer cell, HL-60, by scanning and transmission electron microscopies. The natural and analog peptides have comparable secondary structures as shown by circular dichroism measurements. This indicates that the potency of the peptides on cell membranes is dependent of the helical characteristics rather than the helical strength. The microscopic results show that the morphological changes of the cells treated with CB are distinguishably different from those treated with CB-1/CB-2, which are designed to have enhanced anti-cancer properties by having an extra amphipathic alpha-helix. The morphological differences may be due to their different modes of action on the cell membranes resulting in the different potencies with lower lethal concentration and higher concentration of 50% inhibition (IC50) of CB on bacterium and cancer cell, respectively, as compared with CB-1/:CB-2 (Chen et al. 1997. Biochim. Biophys. Acta 1336, 171-179). In contrast, CB-3 has little effect on either the bacterium or the cancer cell. These results provide microscopic evidence that different killing pathways are involved with the peptides.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9851369     DOI: 10.1002/(SICI)1099-1387(199811)4:7%3C413::AID-PSC160%3E3.0.CO;2-W

Source DB:  PubMed          Journal:  J Pept Sci        ISSN: 1075-2617            Impact factor:   1.905


  11 in total

1.  A novel targeted therapy of Leydig and granulosa cell tumors through the luteinizing hormone receptor using a hecate-chorionic gonadotropin beta conjugate in transgenic mice.

Authors:  Gabriel Bodek; Susanna Vierre; Adolfo Rivero-Müller; Ilpo Huhtaniemi; Adam J Ziecik; Nafis A Rahman
Journal:  Neoplasia       Date:  2005-05       Impact factor: 5.715

Review 2.  Studies on anticancer activities of antimicrobial peptides.

Authors:  David W Hoskin; Ayyalusamy Ramamoorthy
Journal:  Biochim Biophys Acta       Date:  2007-11-22

3.  Unimolecular study of the interaction between the outer membrane protein OmpF from E. coli and an analogue of the HP(2-20) antimicrobial peptide.

Authors:  Aurelia Apetrei; Alina Asandei; Yoonkyung Park; Kyung-Soo Hahm; Mathias Winterhalter; Tudor Luchian
Journal:  J Bioenerg Biomembr       Date:  2010-02-24       Impact factor: 2.945

4.  Bacteriocins: Not Only Antibacterial Agents.

Authors:  Djamel Drider; Farida Bendali; Karim Naghmouchi; Michael L Chikindas
Journal:  Probiotics Antimicrob Proteins       Date:  2016-12       Impact factor: 4.609

5.  Anti-proliferative effect on a colon adenocarcinoma cell line exerted by a membrane disrupting antimicrobial peptide KL15.

Authors:  Yu-Ching Chen; Tsung-Lin Tsai; Xin-Hong Ye; Thy-Hou Lin
Journal:  Cancer Biol Ther       Date:  2015       Impact factor: 4.742

Review 6.  Human defensins.

Authors:  Josef Johann Schneider; Angela Unholzer; Martin Schaller; Monika Schäfer-Korting; Hans Christian Korting
Journal:  J Mol Med (Berl)       Date:  2005-04-09       Impact factor: 4.599

7.  Characterization of antimicrobial peptide activity by electrochemical impedance spectroscopy.

Authors:  William K Chang; William C Wimley; Peter C Searson; Kalina Hristova; Mikhail Merzlyakov
Journal:  Biochim Biophys Acta       Date:  2008-07-01

Review 8.  Bacteriocins as Potential Anticancer Agents.

Authors:  Sumanpreet Kaur; Sukhraj Kaur
Journal:  Front Pharmacol       Date:  2015-11-10       Impact factor: 5.810

Review 9.  Current scenario of peptide-based drugs: the key roles of cationic antitumor and antiviral peptides.

Authors:  Kelly C L Mulder; Loiane A Lima; Vivian J Miranda; Simoni C Dias; Octávio L Franco
Journal:  Front Microbiol       Date:  2013-10-31       Impact factor: 5.640

10.  Tumor cell death mediated by peptides that recognize branched intermediates of DNA replication and repair.

Authors:  Mamon Dey; Sukanya Patra; Leo Y Su; Anca M Segall
Journal:  PLoS One       Date:  2013-11-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.